An internationally recognized scientific leader with an outstanding record of innovation in genomics, genome technologies, or related disciplines; Demonstrated ability to translate scientific vision into scalable, high‑throughput operations, including oversight of large‑scale sequencing production, cost optimization, and delivery against project timelines; Demonstrated success leading large multidisciplinary scientific organizations and complex collaborative research programs, including serving as PI or Co-PI on externally funded research programs (e.g., NIH grants); Established record of high-impact scientific publications; Demonstrated success developing strategic partnerships with academic institutions, government agencies, and industry; Experience managing multimillion-dollar scientific programs and operating budgets; Demonstrated ability to translate emerging technologies into scalable research platforms; Deep knowledge of next-generation sequencing technologies and genomic analysis; 10+ years of management experience with a strong commitment to developing teams; Exceptional ability to bridge scientific vision with operational execution; Strong communication, collaboration, and influencing skills across scientific and administrative stakeholders; Ability to thrive in a dynamic, evolving, and research-driven environment. Accountable for execution of sequencing operations in support of scientifically driven projects and grants; Oversees prioritization and delivery of research projects, ensuring alignment with grant commitments and scientific objectives; Drives improvements in efficiency, scalability, and quality of sequencing operations; Oversees adoption and implementation of new sequencing technologies and methodologies; Provides deep expertise in next-generation sequencing (NGS) and related technologies; Optimizes laboratory capacity, resource allocation, and operational workflows to maximize efficiency, meet project timelines, and support institutional research priorities; Partners with Finance to develop and maintain sustainable pricing and cost-recovery models for genomics services; Monitors external market trends, competitive genomics capabilities, and emerging technologies to inform strategic planning and maintain operational excellence; Negotiates strategic agreements with technology vendors, suppliers, and external partners to optimize cost, service quality, and access to innovative genomic technologies.